InflaRx Financials - Benzinga

InflaRx NV

IFRXNASDAQ

Trade with Public

Trade with Public

$2.27

0.00090.04%

Last update: Aug 28, 2:53 PM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Options Stock Report

InflaRx Financials

InflaRx (IFRX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
InflaRx Q2 EPS $(0.10) Misses $(0.08) Estimate

InflaRx (NASDAQ:IFRX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 58.33 percent increase over losses of $(0.24) per share from the same

Benzinga Newsdesk

PRO
InflaRx Q4 EPS $(0.17) Beats $(0.18) Estimate, Sales $(39.501K) Miss $230.000K Estimate

InflaRx (NASDAQ:IFRX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 88.89 percent decrease over losses of $(0.09) per share from the same

Benzinga Newsdesk

Earnings Scheduled For March 19, 2026

Benzinga Insights

InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway

InflaRx outlines restructuring plans, workforce cuts, and reduced Gohibic spending to extend cash runway and focus development efforts on izicopan through mid-2027.

Vandana Singh

PRO
InflaRx Q2 EPS $(0.24) Misses $(0.17) Estimate, Sales $44.708K Miss $50.167K Estimate

InflaRx (NASDAQ:IFRX) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.17) by 38.73 percent. This is a 7.69 percent increase over losses of $(0.26) per share from the same

Benzinga Newsdesk

Earnings Scheduled For August 7, 2025

Benzinga Insights